American Cancer Society urges COVID-19 booster efforts among immunocompromised patients
Fox News
Ahead of an anticipated FDA authorization for COVID-19 booster vaccines among certain individuals with weakened immune systems, the American Cancer Society has voiced full support behind efforts to offer cancer patients greater protection against COVID-19.
HIV and cancer patients, organ transplant recipients and those taking immunosuppressant drugs comprise about 2.7% of the U.S. adult population, and growing evidence has indicated the population doesn’t respond as well to COVID-19 vaccines, inducing lower levels of protective antibodies. Emerging data suggests an additional dose could boost the antibody response. "As an organization dedicated to improving the lives of cancer patients and their families, the American Cancer Society strongly supports efforts to protect and improve the health and well-being of our community," Dr. Karen E. Knudsen, CEO of the American Cancer Society and American Cancer Society Cancer Action Network, told Fox News.More Related News